The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant durvalumab and tremelimumab in resectable locally advanced SCC of the oral cavity: DUTRELASCO study.
 
Michel Bila
No Relationships to Disclose
 
Amelie Franken
No Relationships to Disclose
 
Jeroen Van Dessel
No Relationships to Disclose
 
Sigrid Hatse
No Relationships to Disclose
 
Karolien Goffin
No Relationships to Disclose
 
Vincent Vandecaveye
No Relationships to Disclose
 
Esther Hauben
No Relationships to Disclose
 
Vincent Vander Poorten
No Relationships to Disclose
 
Diether Lambrechts
No Relationships to Disclose
 
Paul M. Clement
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); LEO Pharma (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MSD Belgium BVBA (Inst); Orbus Therapeutics (Inst); Rakuten Medical (Inst); Takeda (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst)